Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Cells of the Epidermis

Cells of the Epidermis

The epidermis is made of four or five layers of epithelial cells, depending on its location in the body. From deep to superficial, these layers are the stratum basale, stratum spinosum, stratum granulosum, stratum lucidum, and stratum corneum.
The cells in all these layers except the stratum basale are called keratinocytes, a type of cell that manufactures and stores the protein keratin. The keratinocytes in the stratum corneum are dead and regularly slough away, being replaced by cells from...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

ESMO open·2024

Same author

Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors.

Journal of cancer research and clinical oncology·2022

Same author

Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma.

Journal of cancer research and clinical oncology·2022

Same author

The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy.

Journal of cancer research and clinical oncology·2022

Same author

Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studies.

The British journal of dermatology·2021

Same author

Comparison of mutation profiles in primary melanomas and corresponding nodal naevi using next-generation sequencing.

Clinical and experimental dermatology·2021

Same journal

The ethical obligation to use positive trial results.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same journal

Lorlatinib: The Crown Jewel of ALK Inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same journal

TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same journal

When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same journal

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same journal

Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Merkel Cell Polyomavirus Infection and Detection

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

Merkel cell carcinoma.

¹Division of General Dermatology, Medical University of Graz, Graz, Austria. juergen.becker@medunigraz.at

Annals of Oncology : Official Journal of the European Society for Medical Oncology

|October 15, 2010

Summary

This summary is machine-generated.

Merkel cell carcinoma (MCC), a rare and aggressive skin cancer, is increasing in incidence and has a higher mortality rate than melanoma. Understanding MCC pathogenesis and treatment for locoregional disease is crucial.

More Related Videos

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Patient Derived Cell Culture and Isolation of CD133⁺ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Related Experiment Videos

Last Updated: Jun 8, 2026

Merkel Cell Polyomavirus Infection and Detection

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Patient Derived Cell Culture and Isolation of CD133⁺ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Area of Science:

Oncology
Dermatology
Pathogenesis of Skin Cancer

Background:

Merkel cell carcinoma (MCC) is a rare but highly aggressive neuroendocrine skin cancer.
The incidence of MCC is rapidly increasing, with an estimated 1500 new cases in the USA in 2008.
MCC's incidence is projected to surpass that of cutaneous T-cell lymphoma.

Purpose of the Study:

To highlight the increasing incidence and high mortality rate of Merkel cell carcinoma.
To underscore the challenges in understanding MCC pathogenesis and treatment.
To emphasize the need for more research into MCC, particularly for locoregional disease therapy.

Main Methods:

This abstract does not detail specific methods.
It focuses on summarizing clinical observations and incidence data.
It reviews the current understanding of MCC pathogenesis and therapeutic approaches.

Main Results:

Merkel cell carcinoma exhibits a high mortality rate of 33%, exceeding that of cutaneous melanoma.
The incidence of MCC is rising significantly, posing a growing public health concern.
Reliable therapeutic data for MCC are currently limited, primarily to locoregional disease.

Conclusions:

Merkel cell carcinoma represents a significant and growing challenge in dermatological oncology.
Further research into the pathogenesis and treatment of MCC is urgently needed.
The high mortality and increasing incidence necessitate improved understanding and therapeutic strategies for this aggressive skin cancer.